Benjamin Daverman

Benjamin Daverman has served as a member of Maravai LifeSciences board since March 2016. Mr. Daverman joined Vantive Health LLC (formerly known as Baxter Kidney Care), a healthcare company, in January 2025, where he is currently Executive Vice President, Chief Strategy and Business Development Officer. Prior to joining Vantive, Mr. Daverman was a Managing Director and Co-Head of the Healthcare Group at GTCR. Prior to joining GTCR, he worked as a Venture Capitalist at Alta Partners, a venture capital firm, as well as an Investment Banking Associate at JMP Securities and an Analyst in the mergers and acquisitions group at J.P. Morgan (formerly Hambrecht & Quist), both investment banking firms. Mr. Daverman holds an MBA from the Wharton School at the University of Pennsylvania and a BA in History from Colgate University. Mr. Daverman also holds an MS in Biotechnology from the School of Engineering and Applied Science at the University of Pennsylvania.